Company / Current Assets
PALVELLA THERAPEUTICS, INC. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$88.2M
FY2024
5-year range
$7.5M / $127.6M
FY2020-FY2024
Trend
+1069.0%
vs FY2023
Sector context
#207 of 213
Health Care
What the data says
Current Assets changed +1069% YoY in FY2024, a notable deviation from the 9-year average annual change of +132%.
Based on SEC 10-K filings.
$88M in FY2024 with a 5-year CAGR of -5.2%.
Improved from $73M to $88M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -11.6%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 213This company $88.2M Sector average $2.5B
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.2%, indicating a declining trend.
- In FY2024, current assets increased 1069.0% year-over-year.
- Ranks #207 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $88.2M | +1069.0% |
| FY2023 | $7.5M | -89.7% |
| FY2022 | $73.4M | -42.5% |
| FY2021 | $127.6M | +68.5% |
| FY2020 | $75.7M | -34.2% |
| FY2019 | $115.0M | -15.0% |
| FY2018 | $135.4M | +50.8% |
| FY2017 | $89.8M | +174.8% |
| FY2016 | $32.7M | +3.2% |
| FY2015 | $31.7M | +59.9% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026